✦ LIBER ✦

A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene

✍ Scribed by Polák, J; Zemanová, Z; Michalová, K; Klamová, H; Čermák, J; Haškovec, C

Book ID: 110053742
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 23 KB
Volume: 12
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2400913

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concamitant expression of the rare E1/A3

Concamitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient

✍ Martinelli, G; Amabile, M; Terragna, C; Testoni, N; Ottaviani, E; Montefusco, V; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 181 KB

Rearrangement of the BCR/ABL and TCR-β g

Rearrangement of the BCR/ABL and TCR-β genes in lymph node blast crisis diagnosed of chronic myeloid leukemia

✍ A. Villegas; F. A. González 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

The e19a2 BCR/ABL fusion transcript with

The e19a2 BCR/ABL fusion transcript with additional chromosomal aberrations on a new case of chronic myeloid leukemia (CML) of mild type

✍ Bertorelle, R; Bonaldi, L; Bianchini, E; Ramazzina, E; Del Mistro, A; Zamboni, S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 157 KB

Author's reply to “rearrangement of the

Author's reply to “rearrangement of the BCR/ABL and TCR-β genes in lymph node blast crisis diagnosed of chronic myeloid leukemia”

✍ R. van der Jagt; J. Drouin; A. Giulivi; L. B. Huebsch; P. Tittley 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Is it possible to discontinue imatinib m

Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature

✍ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o

Internal tandem duplications of the FLT3

Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy

✍ Christiansen, DH; Pedersen-Bjergaard, J 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB